RDNT RadNet Inc.

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet’s AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

  • Program will increase access to cutting-edge AI-powered breast cancer detection and is designed to boost compliance with annual cancer-screening guidelines
  • Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group are affiliates of one of Southern California’s largest health networks, which manages nearly 600,000 members from newborns to Medicare recipients
  • Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group contract with most major health insurance carriers, expanding access to quality care to communities across Southern California
  • Program is indicative of EBCD reimbursement traction RadNet is getting with commercial payors

LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announced that Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group, affiliates of Heritage Provider Network (HPN), one of the largest physician-owned medical groups in Southern California, have agreed to reimburse RadNet for its EBCD program -- which will now be included as a benefit in their members’ health plans.

These medical groups predominantly located in Los Angeles, Ventura, Orange, San Bernardino, Riverside and San Diego counties, will now provide the AI-powered breast cancer detection services to all of their mammogram-eligible patients. Additionally, RadNet will launch an ongoing patient-outreach program to increase compliance within these medical groups with annual screening guidelines, by proactively contacting eligible patients to encourage and remind them to make their mammography appointments.

Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “RadNet and the Regal, Lakeside and ADOC medical groups share a commitment to early detection of breast cancer and population health screening. One in eight women will develop breast cancer in her lifetime, making it critical to detect the disease early, when treatment options are most optimal. The AI-powered EBCD program is able to detect breast cancer that otherwise would be found much later, thereby improving patient outcomes by reducing the amount of treatment and/or life impact through early detection.”

“We are excited that Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group are now offering this program to all of their eligible female patients. We recognize their commitment to provide innovative solutions to their patients, and expect that they will pave the way for other significant payors to include EBCD in their benefit plans,” concluded Dr. Berger.

Will Jukes, Senior Vice President of Regional Operations at Regal Medical Group, added, “We continually seek ways to bring leading-edge solutions to patient care. EBCD will increase early cancer detection in addition to traditional radiologist screening, eliminating multiple radiology visits and positively impacting patient outcomes. The collaboration with RadNet will also focus on increasing annual compliance with screening mammography guidelines. Bringing this unique breast cancer screening program to our members is illustrative of our commitment to providing new and leading-edge medicine.”

For media inquiries or further information, please contact:

RadNet, Inc.

Mark Stolper, (310) 445-2800

Executive Vice President and Chief Financial Officer

About Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Groups are affiliates of Heritage Provider Network (HPN), which serves as a trusted healthcare network to nearly 600,000 Southern California members. As one of the largest doctor-owned medical groups in Southern California, HPN and its affiliates are dedicated to providing quality, affordable healthcare. For more information, please visit , , or 

About RadNet, Inc.

RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 401 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 employees. For more information, visit .



EN
09/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RadNet Inc.

 PRESS RELEASE

RadNet Announces the Agenda for its November 11, 2025 Investor Day

RadNet Announces the Agenda for its November 11, 2025 Investor Day LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company’s Investor Day. The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can request such consideration b...

 PRESS RELEASE

RadNet to Host Investor Day on November 11, 2025

RadNet to Host Investor Day on November 11, 2025 LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of outpatient imaging centers and digital health and AI solutions, today announced that it will host an Investor Day at the Nasdaq MarketSite in New York City on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time. To view the agenda and event participants as well as access a link for a live webcast, investors are invited to visit . Th...

 PRESS RELEASE

RadNet, Inc. Announces Date of its Third Quarter 2025 Financial Result...

RadNet, Inc. Announces Date of its Third Quarter 2025 Financial Results Conference Call LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its third quarter 2025 financial results on Monday, November 10, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet’s conference ca...

 PRESS RELEASE

RadNet, Inc. to Present at the Jefferies Healthcare Services Conferenc...

RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025 LOS ANGELES, Sept. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies Healthcare Services Conference on Monday, September 29, 2025 at 1:50 p.m. C...

Radnet Inc: 1 director

A director at Radnet Inc sold 35,000 shares at 73.890USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch